1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc, 2019, 94(8): 1623-1640.
|
3. |
Mountain CF. A new international staging system for lung cancer. Chest, 1986, 89(4 Suppl): 225S-233S.
|
4. |
Huang J, Osarogiagbon RU, Giroux DJ, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the N descriptors in the forthcoming 9th edition of the TNM classification for lung cancer. J Thorac Oncol, 2024, 4: S1556-0864(24)00060-1.
|
5. |
Osaki T, Nagashima A, Yoshimatsu T, et al. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer, 2004, 43(2): 151-157.
|
6. |
Martini N, Flehinger BJ, Nagasaki F, et al. Prognostic significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg, 1983, 86(5): 646-653.
|
7. |
Riquet M, Manac'h D, Le Pimpec-Barthes F, et al. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg, 1999, 67(6): 1572-1576.
|
8. |
Varlotto JM, Medford-Davis LN, Recht A, et al. Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2011, 81(2): 353-359.
|
9. |
Tsitsias T, Okiror L, Veres L, et al. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery. Lung Cancer, 2021, 151: 84-90.
|
10. |
Lee JG, Lee CY, Park IK, et al. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Ann Thorac Surg, 2008, 85(1): 211-215.
|
11. |
Fukui T, Mori S, Yokoi K, et al. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol, 2006, 1(2): 120-125.
|
12. |
Giuliano AE, Connolly JL, Edge SB, et al. Breast cancer: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin, 2017, 67(4): 290-303.
|
13. |
Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the esophagus and esophagogastric junction: An eighth edition staging primer. J Thorac Oncol, 2017, 12(1): 36-42.
|
14. |
Sano T, Coit DG, Kim HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association Staging Project. Gastric Cancer, 2017, 20(2): 217-225.
|
15. |
Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest, 2009, 136(1): 260-271.
|
16. |
Rusch VW, Crowley J, Giroux DJ, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol, 2007, 2(7): 603-612.
|
17. |
Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol, 2015, 10(12): 1675-1684.
|
18. |
Xu L, Su H, She Y, et al. Which N descriptor is more predictive of prognosis in resected non-small cell lung cancer: The number of involved nodal stations or the location-based pathological N stage? Chest, 2021, 159(6): 2458-2469.
|
19. |
Park BJ, Kim TH, Shin S, et al. Recommended change in the N descriptor proposed by the International Association for the Study of Lung Cancer: A validation study. J Thorac Oncol, 2019, 14(11): 1962-1969.
|
20. |
Yun JK, Lee GD, Choi S, et al. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer. Eur J Cardiothorac Surg, 2019, 56(5): 849-857.
|
21. |
Dziedzic DA, Cackowski MM, Zbytniewski M, et al. The influence of the number of lymph nodes removed on the accuracy of a newly proposed N descriptor classification in patients with surgically-treated lung cancer. Surg Oncol, 2021, 37: 101514.
|
22. |
Osarogiagbon RU, Van Schil P, Giroux DJ, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Overview of challenges and opportunities in revising the nodal classification of lung cancer. J Thorac Oncol, 2023, 18(4): 410-418.
|
23. |
Rami-Porta R. Future perspectives on the TNM staging for lung cancer. Cancers (Basel), 2021, 13(8): 1940.
|
24. |
Saji H, Tsuboi M, Yoshida K, et al. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer. J Thorac Oncol, 2011, 6(11): 1865-1871.
|
25. |
Wei S, Asamura H, Kawachi R, et al. Which is the better prognostic factor for resected non-small cell lung cancer: The number of metastatic lymph nodes or the currently used nodal stage classification? J Thorac Oncol, 2011, 6(2): 310-318.
|
26. |
Saji H, Tsuboi M, Shimada Y, et al. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer. Chest, 2013, 143(6): 1618-1625.
|